Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 24 clinical trials
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer

chemotherapy and radiotherapy in Patients with inflammatory breast cancer.

metastasis
epirubicin
trastuzumab
neutrophil count
cyclophosphamide
  • 13 views
  • 07 Nov, 2020
  • 1 location
Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer

This phase II multicentre randomized open-label study will assess the safety and efficacy of Pembrolizumab in combination with standard chemotherapy in inflammatory breast cancer. Pembrolizumab

edema
metastasis
paclitaxel
immunohistochemistry
erbb2
  • 7 views
  • 25 Jan, 2021
  • 22 locations
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer. Radiation therapy uses high energy x-rays to kill

mastectomy
metastasis
platelet count
progesterone
axillary lymph node dissection
  • 54 views
  • 22 Sep, 2021
  • 141 locations
Refining Local-Regional Therapy for IBC

nodes in patients with inflammatory breast cancer. The likelihood of identifying the sentinel lymph nodes in the operating room, using both blue dye and the radioactive substance used for

inflammatory breast cancer
breast carcinoma
carcinoma
  • 0 views
  • 09 Jul, 2021
  • 1 location
Atezolizumab Cobimetinib and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

This phase II trial studies how well atezolizumab, cobimetinib, and eribulin work in treating patients with inflammatory breast cancer that has spread to other places in the body (metastatic

edema
carcinoma
gilbert disease
platelet count
eribulin
  • 1 views
  • 26 Aug, 2021
  • 2 locations
Pembrolizumab in Treating Patients With Hormone Receptor Positive Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

This phase II trial studies how well pembrolizumab works in treating patients with hormone receptor positive inflammatory breast cancer that has not spread to other parts of the body, who are

edema
mastectomy
carcinoma
breast carcinoma
erbb2
  • 66 views
  • 19 Aug, 2021
  • 2 locations
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

This trial will compare the administration of 2 cycles of paclitaxel and cisplatin (DP) versus 4 cycles of CEF as adjuvant chemotherapy for the patients with locally advanced breast cancer and who were pathological partial response to DP as neoadjuvant chemotherapy. Those who had pathological complete response to DP will …

epirubicin
paclitaxel
hormone therapy
breast cancer
adjuvant chemotherapy
  • 1 views
  • 24 Jan, 2021
  • 1 location
Dose-escalation Study of Oral CX-4945

This Phase 1 study of oral CX-4945 is designed to test the safety, tolerability and highest safe dose level of this CK2 inhibitor in patients with advanced solid tumor cancers, Castleman's Disease or Multiple Myeloma.

cancer head
metastasis
cancer
platelet count
inflammatory breast cancer
  • 38 views
  • 07 Nov, 2020
  • 1 location
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

This phase I/II trial studies the side effect and best dose of neratinib and to see how well it works with paclitaxel and with or without pertuzumab and trastuzumab before combination chemotherapy in treating patients with breast cancer that has spread to other places in the body (metastatic). Neratinib may …

edema
carcinoma
metastasis
doxorubicin
probe
  • 12 views
  • 28 Mar, 2021
  • 2 locations
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

This randomized phase II trial studies how well carboplatin and paclitaxel with or without panitumumab work in treating patients with invasive triple negative breast cancer. Drugs used in the chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the …

edema
carcinoma
invasive breast cancer
breast carcinoma
platelet count
  • 0 views
  • 23 Jan, 2021
  • 2 locations